292 related articles for article (PubMed ID: 33046511)
1. Escherichia coli K12 Upregulates Programmed Cell Death Ligand 1 (PD-L1) Expression in Gamma Interferon-Sensitized Intestinal Epithelial Cells via the NF-κB Pathway.
Lee SA; Wang Y; Liu F; Riordan SM; Liu L; Zhang L
Infect Immun; 2020 Dec; 89(1):. PubMed ID: 33046511
[TBL] [Abstract][Full Text] [Related]
2.
Lee SA; Liu F; Yun DY; Riordan SM; Tay ACY; Liu L; Lee CS; Zhang L
J Oral Microbiol; 2021; 13(1):1978732. PubMed ID: 34552702
[No Abstract] [Full Text] [Related]
3. Regulation of programmed death ligand 1 expression by interferon-γ and tumour necrosis factor-α in canine tumour cell lines.
Owaki R; Deguchi T; Konnai S; Maekawa N; Okagawa T; Hosoya K; Kim S; Sunaga T; Okumura M
Vet Comp Oncol; 2023 Jun; 21(2):279-290. PubMed ID: 36802270
[TBL] [Abstract][Full Text] [Related]
4. Inflammatory cytokines IL-17 and TNF-α up-regulate PD-L1 expression in human prostate and colon cancer cells.
Wang X; Yang L; Huang F; Zhang Q; Liu S; Ma L; You Z
Immunol Lett; 2017 Apr; 184():7-14. PubMed ID: 28223102
[TBL] [Abstract][Full Text] [Related]
5. Nafamostat mesilate, a serine protease inhibitor, suppresses interferon-gamma-induced up-regulation of programmed cell death ligand 1 in human cancer cells.
Homma S; Hayashi K; Yoshida K; Sagawa Y; Kamata Y; Ito M
Int Immunopharmacol; 2018 Jan; 54():39-45. PubMed ID: 29100036
[TBL] [Abstract][Full Text] [Related]
6. MicroRNA-155 induction via TNF-α and IFN-γ suppresses expression of programmed death ligand-1 (PD-L1) in human primary cells.
Yee D; Shah KM; Coles MC; Sharp TV; Lagos D
J Biol Chem; 2017 Dec; 292(50):20683-20693. PubMed ID: 29066622
[TBL] [Abstract][Full Text] [Related]
7. Licochalcone A inhibits interferon-gamma-induced programmed death-ligand 1 in lung cancer cells.
Yuan LW; Jiang XM; Xu YL; Huang MY; Chen YC; Yu WB; Su MX; Ye ZH; Chen X; Wang Y; Lu JJ
Phytomedicine; 2021 Jan; 80():153394. PubMed ID: 33130472
[TBL] [Abstract][Full Text] [Related]
8. NF-kappaB-dependent synergistic regulation of CXCL10 gene expression by IL-1beta and IFN-gamma in human intestinal epithelial cell lines.
Yeruva S; Ramadori G; Raddatz D
Int J Colorectal Dis; 2008 Mar; 23(3):305-17. PubMed ID: 18046562
[TBL] [Abstract][Full Text] [Related]
9. [Study on the molecular expression and regulation of toll pathway in HT-29 cells].
Chen X; Ouyang Q
Sichuan Da Xue Xue Bao Yi Xue Ban; 2010 Jul; 41(4):581-5. PubMed ID: 20848773
[TBL] [Abstract][Full Text] [Related]
10. Development, validation and implementation of an in vitro model for the study of metabolic and immune function in normal and inflamed human colonic epithelium.
Pedersen G
Dan Med J; 2015 Jan; 62(1):B4973. PubMed ID: 25557335
[TBL] [Abstract][Full Text] [Related]
11. CD137 ligand feedback upregulates PD-L1 expression on lung cancer via T cell production of IFN-γ.
Wang H; Yan Z; Hao J; Yang B; Wang J; Yi L; Wang X; Li S; Zhang H; Zhang S
Thorac Cancer; 2019 Dec; 10(12):2225-2235. PubMed ID: 31625289
[TBL] [Abstract][Full Text] [Related]
12. The IFN-γ/PD-L1 axis between T cells and tumor microenvironment: hints for glioma anti-PD-1/PD-L1 therapy.
Qian J; Wang C; Wang B; Yang J; Wang Y; Luo F; Xu J; Zhao C; Liu R; Chu Y
J Neuroinflammation; 2018 Oct; 15(1):290. PubMed ID: 30333036
[TBL] [Abstract][Full Text] [Related]
13. Farnesyltransferase inhibitor FTI-277 inhibits PD-L1 expression on septic spleen lymphocytes and promotes spleen lymphocyte activation.
Li W; Tu J; Liu X; Yang W
Clin Exp Immunol; 2017 Oct; 190(1):8-18. PubMed ID: 28556912
[TBL] [Abstract][Full Text] [Related]
14. Expression of Programmed Death-Ligand 1 by Human Colonic CD90
Beswick EJ; Grim C; Singh A; Aguirre JE; Tafoya M; Qiu S; Rogler G; McKee R; Samedi V; Ma TY; Reyes VE; Powell DW; Pinchuk IV
Front Immunol; 2018; 9():1125. PubMed ID: 29910803
[TBL] [Abstract][Full Text] [Related]
15. PD-L1 induced by IFN-γ from tumor-associated macrophages via the JAK/STAT3 and PI3K/AKT signaling pathways promoted progression of lung cancer.
Zhang X; Zeng Y; Qu Q; Zhu J; Liu Z; Ning W; Zeng H; Zhang N; Du W; Chen C; Huang JA
Int J Clin Oncol; 2017 Dec; 22(6):1026-1033. PubMed ID: 28748356
[TBL] [Abstract][Full Text] [Related]
16. Regulation of PD-L1 expression in non-small cell lung cancer by interleukin-1β.
Hirayama A; Tanaka K; Tsutsumi H; Nakanishi T; Yamashita S; Mizusaki S; Ishii Y; Ota K; Yoneshima Y; Iwama E; Okamoto I
Front Immunol; 2023; 14():1192861. PubMed ID: 37441079
[TBL] [Abstract][Full Text] [Related]
17. [Inflammatory factors promote the expression of PD-L1 in Tca8113].
Lu LB; Chen J; Feng Y; Zhou CC; Zhang P
Sichuan Da Xue Xue Bao Yi Xue Ban; 2013 Jan; 44(1):42-5. PubMed ID: 23600206
[TBL] [Abstract][Full Text] [Related]
18. Lactobacillus plantarum inhibited the inflammatory response induced by enterotoxigenic Escherichia coli K88 via modulating MAPK and NF-κB signalling in intestinal porcine epithelial cells.
Yang J; Qiu Y; Hu S; Zhu C; Wang L; Wen X; Yang X; Jiang Z
J Appl Microbiol; 2021 May; 130(5):1684-1694. PubMed ID: 32870564
[TBL] [Abstract][Full Text] [Related]
19. Mitogen-activated protein kinase phosphatase-1 controls PD-L1 expression by regulating type I interferon during systemic Escherichia coli infection.
Barley TJ; Murphy PR; Wang X; Bowman BA; Mormol JM; Mager CE; Kirk SG; Cash CJ; Linn SC; Meng X; Nelin LD; Chen B; Hafner M; Zhang J; Liu Y
J Biol Chem; 2022 May; 298(5):101938. PubMed ID: 35429501
[TBL] [Abstract][Full Text] [Related]
20. Programmed Death Ligand 1 Indicates Pre-Existing Adaptive Immune Response by Tumor-Infiltrating CD8
Li YM; Yu JM; Liu ZY; Yang HJ; Tang J; Chen ZN
Int J Mol Sci; 2019 Oct; 20(20):. PubMed ID: 31627272
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]